Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INCCPIX · Entity 6757 | Director · Chairman and CEO · 10% owner | March 18, 2026 | March 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CUMBERLAND PHARMACEUTICALS INC
Report date March 18, 2026 · Filed March 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.80 · Expires 2036-03-18 | Direct | 568,000 |
Reported balance
After 2026-03-18 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-03-18 · Grant · Acquired 100,000 · Balance 568,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 19, 2025 Filed Apr 4, 2025 17:37 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 7 | $5.41 | $37.87 |
DisclosureSEC source: 0001628280-25-016742 · wk-form4_1743788226.xml · nonDerivative · entry 13 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,698,844 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 18, 2025 Filed Apr 4, 2025 17:37 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 7 | $5.12 | $35.84 |
DisclosureSEC source: 0001628280-25-016742 · wk-form4_1743788226.xml · nonDerivative · entry 12 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,698,837 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 21:09 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | GrantOptions (right to buy) · Derivative | 100,000 | $5.17 Strike: $5.17 | $517,000.00 |
DisclosureSEC source: 0001628280-25-013522 · wk-form4_1742332139.xml · derivative · entry 2 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 468,000 Underlying: Common Stock · 100,000 shares Expires 2030-03-17 Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 21:09 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | Tax withholdingCommon Stock | 3,558 | $5.17 | $18,394.86 |
DisclosureSEC source: 0001628280-25-013522 · wk-form4_1742332139.xml · nonDerivative · entry 1 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,698,738 F1 · shares: This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares. Read SEC document |
| March 17, 2025 Filed Apr 4, 2025 17:37 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 7 | $5.41 | $37.87 |
DisclosureSEC source: 0001628280-25-016742 · wk-form4_1743788226.xml · nonDerivative · entry 11 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,698,830 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 14, 2025 Filed Apr 4, 2025 17:37 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 7 | $5.38 | $37.66 |
DisclosureSEC source: 0001628280-25-016742 · wk-form4_1743788226.xml · nonDerivative · entry 10 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,698,823 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 13, 2025 Filed Apr 4, 2025 17:37 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 7 | $5.47 | $38.29 |
DisclosureSEC source: 0001628280-25-016742 · wk-form4_1743788226.xml · nonDerivative · entry 9 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,698,816 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 12, 2025 Filed Apr 4, 2025 17:37 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 7 | $5.17 | $36.19 |
DisclosureSEC source: 0001628280-25-016742 · wk-form4_1743788226.xml · nonDerivative · entry 8 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,698,809 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 11, 2025 Filed Apr 4, 2025 17:37 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 7 | $4.85 | $33.95 |
DisclosureSEC source: 0001628280-25-016742 · wk-form4_1743788226.xml · nonDerivative · entry 7 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,698,802 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 10, 2025 Filed Apr 4, 2025 17:37 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 7 | $5.85 | $40.95 |
DisclosureSEC source: 0001628280-25-016742 · wk-form4_1743788226.xml · nonDerivative · entry 6 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,698,795 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 07, 2025 Filed Apr 4, 2025 17:37 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 10 | $6.51 | $65.10 |
DisclosureSEC source: 0001628280-25-016742 · wk-form4_1743788226.xml · nonDerivative · entry 5 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,698,788 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 06, 2025 Filed Apr 4, 2025 17:37 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 10 | $6.57 | $65.70 |
DisclosureSEC source: 0001628280-25-016742 · wk-form4_1743788226.xml · nonDerivative · entry 4 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,698,778 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 05, 2025 Filed Apr 4, 2025 17:37 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 10 | $6.75 | $67.50 |
DisclosureSEC source: 0001628280-25-016742 · wk-form4_1743788226.xml · nonDerivative · entry 3 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,698,768 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 04, 2025 Filed Apr 4, 2025 17:37 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 10 | $5.11 | $51.10 |
DisclosureSEC source: 0001628280-25-016742 · wk-form4_1743788226.xml · nonDerivative · entry 2 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,698,758 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| March 03, 2025 Filed Apr 4, 2025 17:37 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 10 | $5.54 | $55.40 |
DisclosureSEC source: 0001628280-25-016742 · wk-form4_1743788226.xml · nonDerivative · entry 1 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,698,748 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024. Read SEC document |
| December 20, 2024 Filed Dec 31, 2024 00:44 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 39 | $2.35 | $91.65 |
DisclosureSEC source: 0001628280-24-052606 · wk-form4_1735605852.xml · nonDerivative · entry 15 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,702,296 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 19, 2024 Filed Dec 31, 2024 00:44 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 40 | $2.33 | $93.20 |
DisclosureSEC source: 0001628280-24-052606 · wk-form4_1735605852.xml · nonDerivative · entry 14 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,702,257 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 18, 2024 Filed Dec 31, 2024 00:44 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 49 | $2.19 | $107.31 |
DisclosureSEC source: 0001628280-24-052606 · wk-form4_1735605852.xml · nonDerivative · entry 13 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,702,217 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 17, 2024 Filed Dec 31, 2024 00:44 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 49 | $2.12 | $103.88 |
DisclosureSEC source: 0001628280-24-052606 · wk-form4_1735605852.xml · nonDerivative · entry 12 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,702,168 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 16, 2024 Filed Dec 31, 2024 00:44 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 49 | $2.21 | $108.29 |
DisclosureSEC source: 0001628280-24-052606 · wk-form4_1735605852.xml · nonDerivative · entry 11 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,702,119 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 13, 2024 Filed Dec 31, 2024 00:44 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 32 | $2.33 | $74.56 |
DisclosureSEC source: 0001628280-24-052606 · wk-form4_1735605852.xml · nonDerivative · entry 10 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,702,070 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 12, 2024 Filed Dec 31, 2024 00:44 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 32 | $2.19 | $70.08 |
DisclosureSEC source: 0001628280-24-052606 · wk-form4_1735605852.xml · nonDerivative · entry 9 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,702,038 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 11, 2024 Filed Dec 31, 2024 00:44 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 32 | $2.29 | $73.28 |
DisclosureSEC source: 0001628280-24-052606 · wk-form4_1735605852.xml · nonDerivative · entry 8 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,702,006 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 10, 2024 Filed Dec 31, 2024 00:44 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 32 | $2.48 | $79.36 |
DisclosureSEC source: 0001628280-24-052606 · wk-form4_1735605852.xml · nonDerivative · entry 7 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,701,974 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 09, 2024 Filed Dec 31, 2024 00:44 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 70 | $1.25 | $87.50 |
DisclosureSEC source: 0001628280-24-052606 · wk-form4_1735605852.xml · nonDerivative · entry 6 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,701,942 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 06, 2024 Filed Dec 31, 2024 00:44 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 70 | $1.20 | $84.00 |
DisclosureSEC source: 0001628280-24-052606 · wk-form4_1735605852.xml · nonDerivative · entry 5 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,701,872 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 05, 2024 Filed Dec 31, 2024 00:44 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 65 | $1.20 | $78.00 |
DisclosureSEC source: 0001628280-24-052606 · wk-form4_1735605852.xml · nonDerivative · entry 4 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,701,802 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 04, 2024 Filed Dec 31, 2024 00:44 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 70 | $1.22 | $85.40 |
DisclosureSEC source: 0001628280-24-052606 · wk-form4_1735605852.xml · nonDerivative · entry 3 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,701,737 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 03, 2024 Filed Dec 31, 2024 00:44 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 70 | $1.26 | $88.20 |
DisclosureSEC source: 0001628280-24-052606 · wk-form4_1735605852.xml · nonDerivative · entry 2 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,701,667 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| December 02, 2024 Filed Dec 31, 2024 00:44 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 70 | $1.33 | $93.10 |
DisclosureSEC source: 0001628280-24-052606 · wk-form4_1735605852.xml · nonDerivative · entry 1 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,701,597 F1 · shares: The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 29, 2024 Filed Dec 5, 2024 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 75 | $1.32 | $99.00 |
DisclosureSEC source: 0001628280-24-050107 · wk-form4_1733436201.xml · nonDerivative · entry 20 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,701,527 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 27, 2024 Filed Dec 5, 2024 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 75 | $1.15 | $86.25 |
DisclosureSEC source: 0001628280-24-050107 · wk-form4_1733436201.xml · nonDerivative · entry 19 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,701,452 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 26, 2024 Filed Dec 5, 2024 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 75 | $1.11 | $83.25 |
DisclosureSEC source: 0001628280-24-050107 · wk-form4_1733436201.xml · nonDerivative · entry 18 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,701,377 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 25, 2024 Filed Dec 5, 2024 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 75 | $1.09 | $81.75 |
DisclosureSEC source: 0001628280-24-050107 · wk-form4_1733436201.xml · nonDerivative · entry 17 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,701,302 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 22, 2024 Filed Dec 5, 2024 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 75 | $1.07 | $80.25 |
DisclosureSEC source: 0001628280-24-050107 · wk-form4_1733436201.xml · nonDerivative · entry 16 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,701,227 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 21, 2024 Filed Dec 5, 2024 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 85 | $1.09 | $92.65 |
DisclosureSEC source: 0001628280-24-050107 · wk-form4_1733436201.xml · nonDerivative · entry 15 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,701,152 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 20, 2024 Filed Dec 5, 2024 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 85 | $1.13 | $96.05 |
DisclosureSEC source: 0001628280-24-050107 · wk-form4_1733436201.xml · nonDerivative · entry 14 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,701,067 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 19, 2024 Filed Dec 5, 2024 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 76 | $1.15 | $87.40 |
DisclosureSEC source: 0001628280-24-050107 · wk-form4_1733436201.xml · nonDerivative · entry 13 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,982 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 18, 2024 Filed Dec 5, 2024 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 76 | $1.18 | $89.68 |
DisclosureSEC source: 0001628280-24-050107 · wk-form4_1733436201.xml · nonDerivative · entry 12 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,906 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 15, 2024 Filed Dec 5, 2024 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 76 | $1.17 | $88.92 |
DisclosureSEC source: 0001628280-24-050107 · wk-form4_1733436201.xml · nonDerivative · entry 11 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,830 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 14, 2024 Filed Dec 5, 2024 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 76 | $1.19 | $90.44 |
DisclosureSEC source: 0001628280-24-050107 · wk-form4_1733436201.xml · nonDerivative · entry 10 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,754 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 13, 2024 Filed Dec 5, 2024 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 76 | $1.20 | $91.20 |
DisclosureSEC source: 0001628280-24-050107 · wk-form4_1733436201.xml · nonDerivative · entry 9 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,678 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 12, 2024 Filed Dec 5, 2024 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 76 | $1.20 | $91.20 |
DisclosureSEC source: 0001628280-24-050107 · wk-form4_1733436201.xml · nonDerivative · entry 8 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,602 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 11, 2024 Filed Dec 5, 2024 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 76 | $1.20 | $91.20 |
DisclosureSEC source: 0001628280-24-050107 · wk-form4_1733436201.xml · nonDerivative · entry 7 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,526 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 08, 2024 Filed Dec 5, 2024 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 76 | $1.18 | $89.68 |
DisclosureSEC source: 0001628280-24-050107 · wk-form4_1733436201.xml · nonDerivative · entry 6 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,450 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 07, 2024 Filed Dec 5, 2024 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 76 | $1.17 | $88.92 |
DisclosureSEC source: 0001628280-24-050107 · wk-form4_1733436201.xml · nonDerivative · entry 5 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,374 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 06, 2024 Filed Dec 5, 2024 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 76 | $1.20 | $91.20 |
DisclosureSEC source: 0001628280-24-050107 · wk-form4_1733436201.xml · nonDerivative · entry 4 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,298 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 05, 2024 Filed Dec 5, 2024 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 76 | $1.20 | $91.20 |
DisclosureSEC source: 0001628280-24-050107 · wk-form4_1733436201.xml · nonDerivative · entry 3 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,222 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 04, 2024 Filed Dec 5, 2024 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 49 | $1.17 | $57.33 |
DisclosureSEC source: 0001628280-24-050107 · wk-form4_1733436201.xml · nonDerivative · entry 2 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,146 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
| November 01, 2024 Filed Dec 5, 2024 22:03 UTC | CUMBERLAND PHARMACEUTICALS INC CPIX · Entity 6757 | PurchaseCommon Stock | 76 | $1.15 | $87.40 |
DisclosureSEC source: 0001628280-24-050107 · wk-form4_1733436201.xml · nonDerivative · entry 1 KAZIMI A J · CIK 0001075050 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,700,097 F1 · shares: The reported purchases occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.